Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma. (Q53606125)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma. |
scientific article |
Statements
Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma. (English)
Jared A Gollob
Catherine J Sciambi
Bercedis L Peterson
Tina Richmond
Monica Thoreson
Kelly Moran
Holly K Dressman
Jaroslav Jelinek
1 August 2006
12
15
4619-4627